Lipid mediators of ultraviolet radiation (UVR) induced skin inflammation
ISRCTN | ISRCTN47896115 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN47896115 |
Secondary identifying numbers | 10920 |
- Submission date
- 20/10/2011
- Registration date
- 20/10/2011
- Last edited
- 18/01/2017
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Skin and Connective Tissue Diseases
Plain English summary of protocol
Background and study aims
When human skin is exposed to sunlight it develops an inflammatory response known as sunburn. This is a major factor for skin damage, premature skin ageing and the development of cancer. We have discovered that very potent fat (lipid) molecules called eicosanoids are produced by the body during the early stages of sunburn. However, there is a lack of studies on how these molecules contribute to resolving skin inflammation. In this study we want to investigate the network of lipids that are responsible for resolving skin inflammation. We wish to study (a) the timing for the production of specific lipids and how this may differ in people who tend to sunburn compared to those who tend to tan, (b) the effect of nutrients contained in fish oils that have been shown to possess sun-protective effects, and to understand (c) how sunlight and nutrients in the diet may affect the manufacture of these lipids and (d) the contribution to this made by different types of skin cells. Understanding how sunburn is resolved will reveal biological markers (biomarkers) related to skin inflammation and can help with the discovery of new treatments.
Who can participate?
Healthy white Caucasian male and female individuals aged between 18 and 60 years.
What does the study involve?
Exposure of the skin on the upper buttock to ultraviolet light (UV), measurements of skin redness, and skin sampling (skin biopsies or skin blisters) from unexposed and UV-exposed areas of the upper buttock. Participants will also take oral omega-3 fatty acid supplements for 3 months.
What are the possible benefits and risks of participating?
Understanding how sunburn is resolved will reveal biomarkers related to skin inflammation and can help with the discovery of new treatments. We do not expect there to be any disadvantage or adverse effect from taking part. You may experience some redness of the skin after the UV exposures. Some discomfort will be felt at the time of skin sampling and in the days following the procedures, which may include redness, irritation and pain at the site. There is also a small risk of infection and bleeding with biopsies. A small permanent scar will be left on your skin at each biopsy site.
Where is the study run from?
The Photobiology Unit at Salford Royal NHS Hospital (Salford, UK).
When is the study starting and how long is it expected to run for?
October 2011 to October 2014.
Who is funding the study?
The Wellcome Trust (UK)
Who is the main contact?
Dr Suzanne Pilkington
Suzanne.pilkington@manchester.ac.uk
Contact information
Scientific
Photobiology Unit, Dermatological Sciences
Hope Hospital
Stott Lane
Salford
M6 8HD
United Kingdom
Phone | +44 161 275 5368 |
---|---|
Suzanne.Pilkington@manchester.ac.uk |
Study information
Study design | Non-randomised, interventional and observational, clinical laboratory study |
---|---|
Primary study design | Interventional |
Secondary study design | Non randomised controlled trial |
Study setting(s) | GP practice |
Study type | Screening |
Participant information sheet | Not available in web format, please use the contact details below to request a patient information sheet |
Scientific title | Identifying the network of lipid mediators responsible for maintenance and resolution of ultraviolet radiation-induced skin inflammation |
Study objectives | The aim of this study is to investigate the network of lipids that are responsible for resolving skin inflammation. A study in healthy adult volunteers and patients with abnormal responses to sunlight i.e. photosensitivity, will assess 1. The timing for the production of specific lipids and how this may differ in people who tend to sunburn compared to those who tend to tan 2. How this may differ between healthy people and those showing abnormal clinical responses to sunlight 3. The effect of nutrients contained in fish oils that have been shown to possess sun-protective effects. Understanding how sunburn is resolved, will increase our understanding of skin inflammation and can facilitate the discovery of new therapeutic agents. |
Ethics approval(s) | NRES Committee North West-GM North, 22/08/2011, ref: 11/NW/0567 |
Health condition(s) or problem(s) studied | Topic: Skin; Subtopic: Skin (all Subtopics); Disease: Dermatology |
Intervention | Omega-3 PUFA (Incromega EPA500TG - fish oil supplements rich in omega-3 PUFAs) administered at 4g daily for 3 months |
Intervention type | Other |
Primary outcome measure | Concentration of bioactive lipids in skin samples following UVR exposure measured at 3 months |
Secondary outcome measures | 1. Number of infiltrating inflammatory/immune cells during and until resolution of UVR induced inflammation measured at 3 months 2. The expression of key bioactive lipid metabolising enzymes and receptors in human skin measured at 3 months |
Overall study start date | 01/10/2011 |
Completion date | 01/10/2014 |
Eligibility
Participant type(s) | Patient |
---|---|
Age group | Adult |
Lower age limit | 18 Years |
Sex | Both |
Target number of participants | Planned Sample Size: 125; UK Sample Size: 125 |
Key inclusion criteria | 1. Healthy, human volunteers and patients with defined photosensitivity conditions. 2. Aged 18 - 60 years 3. Sun reactive skin type I - IV (white Caucasian) 4. Both male & female participants |
Key exclusion criteria | 1. History of skin cancer 2. Taking photoactive or anti-inflammatory medication 3. Sunbathing, sunbed use or phototherapy in the past 3 months 4. Taking nutritional supplements containing polyunsaturated fatty acids (PUFA) 5. Consuming more than 2 portions of oily fish per week 6. Pregnancy 7. Unable to eat fish or gelatine |
Date of first enrolment | 01/10/2011 |
Date of final enrolment | 01/10/2014 |
Locations
Countries of recruitment
- England
- United Kingdom
Study participating centre
M6 8HD
United Kingdom
Sponsor information
University/education
Faculty of Medical and Human Sciences Research Office
3.53 Simon Building
Manchester
M13 9PT
England
United Kingdom
Website | http://www.manchester.ac.uk/ |
---|---|
https://ror.org/027m9bs27 |
Funders
Funder type
Charity
Private sector organisation / International organizations
- Location
- United Kingdom
Results and Publications
Intention to publish date | |
---|---|
Individual participant data (IPD) Intention to share | No |
IPD sharing plan summary | Not provided at time of registration |
Publication and dissemination plan | Not provided at time of registration |
IPD sharing plan |
Editorial Notes
18/01/2017: No publications found in PubMed, verifying study status with principal investigator.
23/07/2013: The anticipated end date was changed from 01/10/2013 to 01/10/2014.